Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy

Clinical Orthopaedics and Related Research

Volumn 426, Issue , 2004, Pages 117-124

  Martin, James A ^a,c   DeYoung, Barry R ^a   Gitelis, Steven ^b   Weydert, Jamie A ^a   Klingelhutz, Aloysius J ^a   Kurriger, Gail ^a   Buckwalter, Joseph A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TELOMERASE REVERSE TRANSCRIPTASE;

CANCER GRADING; CARTILAGE TUMOR; CELL TRANSFORMATION; CHONDROSARCOMA; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCHONDROMA; ENZYME ACTIVITY; ENZYME SUBUNIT; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; TELOMERASE REVERSE TRANSCRIPTASE GENE; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

EID: 4444225846     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000141647.22689.de     Document Type: Conference Paper

References (34)

1. Aigner T: Towards a new understanding and classification of chondrogenic neoplasias of the skeleton: Biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441:219-230, 2002.
2. Aigner T, Muller S, Neureiter D, et al: Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273-2281, 2002.
3. Aue G, Muralidhar B, Schwartz HS, Butler MG: Telomerase activity in skeletal sarcomas. Ann Surg Oncol 5:627-634, 1998.
4. Bickenbach JR, Vormwald-Dogan V, Bachor C, et al: Telomerase is not an epidermal stem cell marker and is down regulated by calcium. J Invest Dermatol 111:1045-1052, 1998.
5. Block JA, Inerot S, Gitelis S, Kimura JH: Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term culture. J Bone Joint Surg 73A:647-658, 1991.
6. Erlemann R: Benign cartilaginous tumors. Radiologe 41:548-559, 2001.
7. Etheridge KT, Banik SS, Armbruster BN, et al: The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277:24764-24770, 2002.
8. Evans HL, Ayala AG, Romsdahl MM: Prognostic factors in chondrosarcoma of bone: A clinicopathologic analysis with emphasis on histologic grading. Cancer 40:818-831, 1977.
9. Flemming DJ, Murphey MD: Enchondroma and chondrosarcoma. Semin Musculoskelet Radiol 4:59-71, 2000.
10. Gitelis S, Bertoni F, Picci P, Campanacci M: Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg 63:1248-1257, 1981.
11. Hackel CG, Krueger S, HJ G, et al: Overexpression of cathepsin b and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer 89:995-1003, 2000.
12. Harle-Bachor C, Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93:6476-6481, 1996.
13. Harley C: Telomerase is not an oncogene. Oncogene 21:494-502, 2002.
14. Harley CB, Kim NW, Prowse KR, et al: Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59:307-315, 1994.
15. Hoos A, Hepp HH, Kaul S, et al: Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 79:8-12, 1998.
16. Kim N, Piatyszek M, Prowse K: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
17. Klingelhutz AJ: The roles of telomeres and telomerase in cellular immortalization and the development of cancer. Anticancer Res 19:4823-4830, 1999.
18. Kunisada T, Moseley JM, Slavin JL, et al: Co-expression of parathyroid hormone-related protein (pthrp) and pth/pthrp receptor in cartilaginous tumours: A marker for malignancy? Pathology 34:133-137, 2002.
19. Marco RA, Gitelis S, Brebach GT, Healey JH: Cartilage tumors: Evaluation and treatment. J Am Acad Orthop Surg 8:292-304, 2000.
20. Martin JA, Forest E, Block JA, et al: Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation. Cell Growth Differ 13:397-407, 2002.
21. Mirra JM, Gold R, Downs J, Eckardt JJ: A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones: A clinicopathologic analysis of 51 cases. Clin Orthop 201:214-237, 1985.
22. Morin G: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes ttaggg repeats. Cell 59:521-529, 1989.
23. Oliveira AM, Sebo TJ, McGrory JE, et al: Extraskeletal myxoid chondrosarcoma: A clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol 13:900-908, 2000.
24. Pateder DB, Gish MW, O'Keefe RJ, et al: Parathyroid hormone-related peptide expression in cartilaginous tumors. Clin Orthop 403:198-204, 2002.
25. Rizzo M, Chert MA, Harrelson JM, Scully SP: Chondrosarcoma of bone: Analysis of 108 cases and evaluation for predictors of outcome. Clin Orthop 391:224-233, 2001.
26. Robinson MO: Telomerase and cancer. Genet Eng (NY) 22:209-222, 2000.
27. Russell WO, Cohen J, Edmonson JH, et al: Staging system for soft-tissue sarcomas. Semin Oncol 8:156-159, 1981.
28. Sangiorgi L, Gobbi GA, Lucarelli E, et al: Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness. Int J Cancer 95:156-161, 2001.
29. Scheel C, Schaefer KL, Jauch A, et al: Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20:3835-3844, 2001.
30. Shay JW, Zou Y, Hiyama E, Wright WE: Telomerase and cancer. Hum Mol Genet 10:677-685, 2001.
31. Soderstrom M, Bohling T, Ekfors T, et al: Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer 100:144-151, 2002.
32. Stefanou DG, Nonni AV, Agnantis NJ, et al: p53/mdm-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: A ten-year follow-up study. Anticancer Res 18:4673-4681, 1998.
33. Wong JM, Kusdra L, Collins K: Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4:731-736, 2002.
34. Yang Y, Chen Y, Zhang C, et al: Nucleolar localization of telomerase reverse transcriptase protein is associated with telomerase function. Exp Cell Res 277:201-209, 2002.